Table: Kringle Pharma -2021/22 parent results

Kringle Pharma

14/11/2022 06:40

Nov 14 (Reuters)- 
          Kringle Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT   
              Sep 30, 2022    Sep 30, 2021     Sep 30, 2023      YEAR     
                 LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales          391 mln         289 mln          68 mln                  
               (+35.2 pct)     (-38.0 pct)     (-82.4 pct)                
  Operating   loss 426 mln    loss 357 mln     loss 993 mln               
  Recurring   loss 330 mln    loss 299 mln     loss 953 mln               
  Net         loss 331 mln    loss 301 mln     loss 955 mln               
  EPS        loss 68.33 yen  loss 72.51 yen  loss 177.50 yen              
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T